Latest Earnings Results: Q2 '26
Estimated EPS
-$1.09
Reported EPS
-$0.75
Surprise
+31.19%
Estimated Rev
$21.95M
Reported Rev
$20.16M
Surprise
-8.17%
$DNA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.75 up 31.82% YoY • Reported revenue of $20.16M down -59.37% YoY • Ginkgo Bioworks Holdings, Inc. reaffirms its expected total cash burn of ($150) million to ($125) million for the full year 2026, consistent with the company's previously stated financial outlook.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$1.16 | -- | -- | N/A |
Q2 '26 | -$1.09 | -$0.75 | 31.19% | BEAT |
Q1 '26 | -$1.21 | -$1.39 | -14.77% | MISSED |
Q4 '25 | -$1.46 | -$1.41 | 3.09% | BEAT |
Q3 '25 | -$1.24 | -$1.45 | -16.82% | MISSED |